Respiratory News: Breaking Respiratory News, Comments and Articles. - Page: 2

EMA issues warnings over codeine use

Children and young adults who have had surgery to remove their tonsils or adenoids to treat sleep apnoea should not receive codeine as pain relief, the European Medicines Agency has stated. The warning follows reports of serious adverse effects and...

Yale Releases the Findings of the Medtronic-Commissioned Infuse Bone Graft Study; Parker Waichman LLP Comments

Yale University researchers this week released the findings of two independent studies of Medtronic’s Infuse bone graft products. Parker Waichman, which offers free legal consultations for victims of Medtronic Infuse Bone Graft Injuries, notes that the results indicate that Infuse allegedly can cause cancer and male infertility, and that early published data was skewed toward the positive. New Y...

Walgreens Third Quarter 2013 Earnings Release, Conference Call Scheduled for June 25

Walgreens (NYSE: WAG) (Nasdaq: WAG) will release its fiscal 2013 third quarter earnings results at 7:30 a.m. Eastern time Tuesday, June 25, followed by a conference call with Walgreens management beginning at 8:30 a.m. Eastern time. The conference call will be simulcast through Walgreens investor relations website at: http://investor.walgreens.com...

Long distance calls by sugar molecules

Glycoproteins are an essential part of our body: These sugar-protein hybrid molecules are what makes the protective mucus that lines our lungs and stomach. They are also part of the fluid that lubricates our joints, the synovial fluid, and cover all...

Royalty ends hostile bid for Elan

Royalty Pharma (New York, N.Y.) withdrew a request for judicial review of a decision by the Irish Takeover Panel regarding its offer to acquire Elan Corp. plc (NYSE:ELN), ending a four-month public spat between the companies. Royalty was seeking to a...

NIH awards $12.7M to repurpose pharma compounds

NIH's National Center for Advancing Translational Science (NCATS) awarded $12.7 million to nine academic research groups to repurpose compounds from pharma partners under a pilot initiative. The groups will evaluate the selected compounds, all of whi...

Today’s Hottest High-Energy Hits & Remixes Gathered for NOW That’s What I Call A Workout 2, Released Today Exclusively on the iTunes Store

NOW That’s What I Call Music!’s First NOW Workout Collection Has Topped iTunes’ Fitness Chart Since its December Debut Since debuting exclusively on iTunes in December, NOW That’s What I Call Music!’s wildly popular NOW That’s What I Call A Workout has held the No. 1 position on iTunes’ Fitness chart. NOW is shaking up the NOW...

Mediware Acquires Fastrack Healthcare Systems, Inc., Homecare Software Pioneer

Increases Mediware’s customer base in the homecare market Mediware Information Systems, Inc. announced today that it has acquired Fastrack Healthcare Systems, Inc., a home medical equipment (HME) and home infusion therapy software solutions company. Mediware acquired more than 300 new customers and the related expertise, products, services and contra...

Baron and Budd Heralds Global Impact of Mesothelioma Patient Janelle Bedel “Wonder Woman”

Cancer Patient Uses Personal Tragedy to Raise Awareness, Inspire Others. Dallas, TX (PRWEB) June 18, 2013 Baron and Budd mesothelioma attorneys are saluting Janelle Bedel, a young mesothelioma patient whose courage has mustered far-reaching influence. “Janelle’s battle against mesothelioma is an inspiration,” said the mesothelioma lawyers at Baron and Budd. “Her global impact on mesothel...

Numera Social Platform Powers New Patient Engagement Program Launched by ResMed

Encouragement, accountability to improve patient compliance with therapy for sleep-disordered breathing Numera, providing customizable solutions for companies interested in improving their offerings for healthy aging, chronic condition management, and post-acute care, announced its collaboration with ResMed on its patient engagement platform called Sl...

Civitas Therapeutics Receives Second Grant for Their Lead Product CVT-301 from The Michael J. Fox Foundation for Parkinson’s Research

$1M Funding to Support Later Stage Clinical Trial of Inhaled Formulation of Levodopa Civitas Therapeutics, Inc., a biopharmaceutical company developing transformative therapeutics using the ARCUS(TM) respiratory delivery platform, today announced it has been selected to receive a second grant from The Michael J. Fox Foundation for Parkinson’s Researc...

Marlton Rehabilitation Hospital Receives 2013 Reader's Choice Award

MARLTON, N.J., June 18, 2013 /PRNewswire/ -- Marlton Rehabilitation Hospital ("Marlton Rehab"), a 51-bed acute inpatient medical rehabilitation hospital (IRF) located in Marlton, New Jersey recently received regional recognition as the "BEST REHAB" by the Courier-Post Reader's Choice Awards - 2013 Best of South Jersey annual reader survey.   Established in 1995, Marlton Rehabili...

Edison Investment - BioAlliance Pharma - Initiation of coverage - Stand and de-Liva

BioAlliance develops drugs for orphan oncology indications and to treat infections. Most of its products are widely used medicines in new formulations for use in novel indications. Its lead oncology product, Livatag, is in Phase III for liver cancer with safety and recruitment data due over the next 18 months. It has two FDA-approved drugs, Oravig (oral thrush) and Sitavig (cold sores). Oravig&r...

MicroDose of Fresh Air for Teva with Respiratory Acquisition

Teva has affirmed its respiratory drug delivery strategy with the purchase of MicroDose Therapeutx for a potential $165m (€123m).

Professional Golfer Jeff Klauk Tees Off New Pledge Campaign for People Living with Epilepsy

ATLANTA, June 18, 2013 /PRNewswire/ -- regulated information — Global biopharmaceutical company UCB, Inc. and professional golfer Jeff Klauk today announced the launch of a new Pledge campaign for people with epilepsy and their loved ones. The Pledge empowers the millions of Americans living with epilepsy to take a stand and make a personal commitment to demand more: greater unders...

Teva to expand respiratory business with up to $165 million acquisition of MicroDose Therapeutx

Israel-based Teva Pharmaceutical Industries (NYSE: TEVA) has entered into a definitive agreement to acquire MicroDose Therapeutx, a privately-held pharmaceutical and drug delivery company focused on inhalation technologies and products for lung disea...

ACTIVAERO RECEIVES RESEARCH GRANT FOR DEVELOPMENT OF THERAPY AGAINST CHRONIC LUNG DISEASES

Activaero GmbH / ACTIVAERO RECEIVES RESEARCH GRANT FOR DEVELOPMENT OF THERAPY AGAINST CHRONIC LUNG DISEASES . Processed and transmitted by Thomson Reuters ONE. The issuer is solely responsible for the content of this announcement. Munich m4 biotech cluster program extends support for the development of a novel method to treat chronic lung diseases   Program focuses on targeted treatment of...

Coming Soon? Roadside Drug Testing

Drug and alcohol addiction can affect your life in so many negative ways and soon, with the help of roadside testing, your driving privileges could be suspended or revoked. Those with a drug addiction should contact a professional detox center like Harbor Village and get the 24/7 medically supervised assistance needed for recovery. Miami, FL (PRWEB) June 18, 2013 According to a HealthDay News art...

Teva Pharmaceutical to take over MicroDose Therapeutx

Teva Pharmaceutical Industries has signed an agreement to purchase pharmaceutical and drug delivery company, MicroDose Therapeutx, to strengthen its respiratory franchise.

Clean the World Now Recycling Hotel Soap in Asia

Facility Serving Macao and Hong Kong to Recycle 110 Tons of Soap in First Year ORLANDO, FL (PRWEB) June 18, 2013 Clean the World, the largest global recycler of hotel amenities, has expanded to Asia. The organization’s new soap recycling facility in Hong Kong provides an essential service to a region quickly running out of landfill space. It is projected to divert 110 tons of soap from landfill...

Researchers launch novel investigation into tuberculosis transmission

(Medical Xpress)—Researchers at Colorado State University are launching the most realistic study ever conducted into how transmission of the tuberculosis pathogen triggers infectious disease, an investigation expected to yield new insights into a d...

International researchers solve three-dimensional structure of respiratory syncytial virus

Young children and the elderly are especially susceptible to respiratory syncytial virus. The three-dimensional structure of respiratory syncytial virus has been solved by an international team from Finland and Switzerland.

Dr. Bernabe Vazquez Speaks on Miami Woman’s Deadly Silicone Butt Injection

Miami, FL (PRWEB) June 18, 2013 Two months ago, Suyima Torres, 28, died from respiratory arrest after going into surgery for a second session of a silicone treatment for gluteus augmentation at Cuerpos Health & Aesthetic in Miami-Dade County...

GPR116 Knockout and Conditional Knockout Mice

Pulmonary surfactant plays a critical role in preventing alveolar collapse by decreasing surface tension at the alveolar air-liquid interface. Surfactant deficiency contributes to the pathogenesis of acute lung injury (ALI) and acute respiratory distress syndrome (ARDS), common disorders that can afflict patients of all ages and carry a mortality rate greater than 25%. Excess surfactant leads to p...

OxySure Systems Signs New Distributor

FRISCO, TX--(Marketwired - June 18, 2013) -  OxySure® Systems, Inc. (OTCQB: OXYS) ("OxySure," or the "Company"), a medical device innovator of life-saving, easy-to-use emergency oxygen solutions with its "oxygen from powder" technology, today announced that it has signed a non-exclusive distributor agreement with Aventric Technologies ("Aventric") to sell OxySure's full portfolio of products. "...